About our merger
Our merger brings together two leading nuclear imaging businesses with complementary strengths, manufacturing capabilities, commercial footprints and operational networks. Our enlarged business will employ over 1,500 people globally, supplying more than 6,000 public and private hospitals around the world. Annually, our combined business will provide potentially life-saving diagnostic solutions to 14 million patients globally.
Nuclear imaging at our core
Nuclear imaging will continue to be at the core of our enlarged business and we plan to invest further in organic and in-organic growth opportunities. We are very excited about our future potential and our ability to deliver substantial benefits to our customers and their patients.